Shopping Cart 0
Cart Subtotal
USD 0

Endologix, Inc. (ELGX)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Endologix, Inc. (ELGX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company's AAA products are built on traditional minimally-invasive endovascular repair (EVAR) platform or endovascular sealing (EVAS) platform. The company's EVAR products include AFX endovascular AAA system Vela Proximal Endograft and Intuitrak endovascular AAA system; and EVAS products comprise Nellix endovascular aneurysm sealing system. It has manufacturing facility in Irvine. The company sells its products to hospitals in the US and Europe through direct sales force and through third-party international distributors and agents in other parts of the world. Endologix is headquartered in California, the US.

Endologix, Inc. Key Recent Developments

May 04,2017: Endologix Reports First Quarter 2017 Financial Results

Apr 04,2017: Endologix Enters into $170 Million Credit Facility with Deerfield Management

Feb 22,2017: Endologix Reports Results for the Fourth Quarter and Full Year 2016

Feb 06,2017: Endologix Announces Appointment of Dan Lemaitre as Chairman of the Board

Nov 01,2016: Endologix Reports Results for the Third Quarter 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Endologix, Inc.-Key Facts 6

Endologix, Inc.-Key Employees 7

Endologix, Inc.-Key Employee Biographies 8

Endologix, Inc.-Major Products and Services 9

Endologix, Inc.-Medical Equipment Pipeline Products Data 10

Endologix, Inc. Pipeline Products by Equipment Type 10

Endologix, Inc. Pipeline Products by Development Stage 11

Endologix, Inc.-History 14

Endologix, Inc.-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2-Company Analysis 17

Endologix, Inc.-Business Description 17

Endologix, Inc.-Corporate Strategy 18

Endologix, Inc.-SWOT Analysis 19

SWOT Analysis-Overview 19

Endologix, Inc.-Strengths 19

Endologix, Inc.-Weaknesses 20

Endologix, Inc.-Opportunities 21

Endologix, Inc.-Threats 22

Endologix, Inc.-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

Endologix, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 30

Endologix, Inc., Medical Equipment, Deals By Type, 2011 to YTD 2017 31

Endologix, Inc., Recent Deals Summary 32

Section 5-Company's Recent Developments 33

May 04, 2017: Endologix Reports First Quarter 2017 Financial Results 33

Apr 04, 2017: Endologix Enters into $170 Million Credit Facility with Deerfield Management 34

Feb 22, 2017: Endologix Reports Results for the Fourth Quarter and Full Year 2016 35

Feb 06, 2017: Endologix Announces Appointment of Dan Lemaitre as Chairman of the Board 37

Nov 01, 2016: Endologix Reports Results for the Third Quarter 2016 38

Oct 25, 2016: Endologix Appoints Matthew Thompson, M.D., as Chief Medical Officer 40

Aug 02, 2016: Endologix Reports Results for the Second Quarter 2016 41

May 09, 2016: Endologix Reports Results for the First Quarter 2016 43

Mar 08, 2016: Endologix Announces First Patients in Japan Treated With Nellix EndoVascular Aneurysm Sealing System 45

Feb 29, 2016: Endologix Announces First U.S. Commercial Implant of AFX2 Bifurcated Endograft System 46

Section 6-Appendix 47

Methodology 47

Ratio Definitions 47

About GlobalData 51

Contact Us 51

Disclaimer 51


List Of Figure

List of Figures

Endologix, Inc. Pipeline Products by Equipment Type 10

Endologix, Inc. Pipeline Products by Development Stage 11

Endologix, Inc., Performance Chart (2012-2016) 27

Endologix, Inc., Ratio Charts 29

Endologix, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 30

Endologix, Inc., Medical Equipment, Deals by Type, 2011 to YTD 2017 31


List Of Table

List of Tables

Endologix, Inc., Key Facts 6

Endologix, Inc., Key Employees 7

Endologix, Inc., Key Employee Biographies 8

Endologix, Inc., Major Products and Services 9

Endologix, Inc. Pipeline Products by Equipment Type 10

Endologix, Inc. Number of Pipeline Products by Development Stage 11

Endologix, Inc. Pipeline Products Summary by Development Stage 12

Endologix, Inc., History 14

Endologix, Inc., Subsidiaries 16

Endologix, Inc., Key Competitors 23

Endologix, Inc., Ratios based on current share price 24

Endologix, Inc., Annual Ratios 25

Endologix, Inc., Annual Ratios (Cont...1) 26

Endologix, Inc., Interim Ratios 28

Endologix, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 30

Endologix, Inc., Medical Equipment, Deals By Type, 2011 to YTD 2017 31

Endologix, Inc., Recent Deals Summary 32

Currency Codes 47

Capital Market Ratios 47

Equity Ratios 48

Profitability Ratios 48

Cost Ratios 49

Liquidity Ratios 49

Leverage Ratios 50

Efficiency Ratios 50

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com